Die Tatsachen: Brustkrebs in den Männern
Männlicher Brustkrebs enthält 1% von allen bestimmten Kästen der Brustes Krebs.
Archiv für Behandlung Kategorie
Die Besonderheiten des venösen Zuganges
Warum eine venöse Zugang Vorrichtung?
Venös, Ader bedeutend, ist der schnellste Weg für das Liefern der Medikation, des Bluts und der Blutprodukte in einer gleichbleibenden und sicheren und leistungsfähigen Weise.
ARTEN DER VENÖSEN ZUGANG VORRICHTUNGEN
Die Zusatzlinie
Zusatzzugang wird mit einer Zusatzader erreicht (Hände, Arme, Füße oder Beine). Im Allgemeinen werden die Hände und die Arme benutzt. Position und Plazierung wird durch den Zustand der Adern des Patienten und den Grund für Zugang festgestellt.
Ein intravenöser Katheter wird mit einer Nadel eingesetzt, die durch eine flexible Hülle bedeckt wird. Nachdem Einfügung die Nadel entfernt ist und des Hülle Remains eingesetzt an eine Nabe angeschlossen. Diese Nabe kann an Schläuche für ununterbrochene intravenöse Therapie (iv) für Blut oder Blutprodukte, Antibiotika oder andere Medikationen dann angeschlossen werden. Häufig, wenn der IV durchgeführt wird und der Aufstellungsort ist noch in gutem Zustand ist, empfängt die Zugang Nabe eine kleine Kappe. Die Kappe wird benutzt, um den Aufstellungsort mit salzigem pro Protokolle zu spülen und ist für zukünftige Medikationanlieferung vorhanden.
Eine sterile Behandlung wird über den Einfügungaufstellungsort gesetzt und der Katheter bleibt an der richtigen Stelle für einige Tage. Diese Aufstellungsorte werden nicht für Blut zeichnet benutzt.
Zentrale venöse Zugang Vorrichtung:
Alle zentralen venösen Zugang Vorrichtungen beziehen Katheterumkippen mit ein, das in der überlegenen Vena Cava des Herzens stillsteht, ausgenommen eine femoral (Leiste) Linie, deren Spitze in der minderwertigen Vena Cava sitzt.
Röntgenstrahl wird benutzt, um die korrekte Plazierung von allem CVADs zu überprüfen.
Ein CVAD wird über einer Zusatzlinie aus vielen Gründen gewählt. Many drugs, especially chemotherapy medications used to treat cancer are damaging to small peripheral veins, resulting in the collapse, scarring or occlusion of the site. This leads to multiple sticks for new peripheral access sites. A CVAD will stay in place for a longer period of time, generally for the entire therapy regime or longer and most patients will go home with the device. Patients are then taught how to care for their CVAD devices at home.
A CVAD may eliminate the need for multiple laboratory blood draws.
Today’s CVAD catheter products enable the infusion of several medications, some incompatible, at the same time.
It is important to discuss with your doctor why you are having a CVAD placed. The more you know about your therapy the more comfortable you will be.
Four Common Types of CVAD:
PICC Line
This CVAD is called a peripherally inserted central catheter (PICC) and is non-surgically placed into the antecubital area of the arm (the front surface of the arm, at the elbow). The catheter which has a guide wire is then threaded to rest in the superior vena cava (the top opening of the heart) Several companies make this device. The photo shows a Bard brand PICC line, however; there are other brand names you may hear about such as Poly PICC or Groshong. Note the lumens or pigtails. These lines may be inserted at beside by a specialist nurse or a physician. These lines may be used for laboratory blood draws.
Who is Prostate Cancer?
He can be any man.
Prostate cancer is the most common cancer in men after lung cancer, affecting one in six men in the U.S.
He is rarely under the age of 40, usually over 50 and in fact two-thirds of all cases are diagnosed in men over 65.
60 to 61% of the time he is an African American male.
He is twice as likely to be diagnosed with prostate cancer if he has/had a father or brother with the disease. There is also an inherited gene for prostate cancer, affecting 5 to 10 % of all diagnosed cases. While research into genetic testing is promising, it is not yet available.
For more information on who is prostate cancer see the Prostate Cancer Foundation site.
The Prostate Cancer Research Foundation of Canada offers a risk assessment quiz on their website.
Seeking Prostate Cancer Survivors for Technology Discussion
Thanks to Lesly Maranan, for passing this along!
From the desk of Dan Ollendorf, MPH, ARM, Chief Review Officer, Institute for Clinical & Economic Review
I am writing concerning the efforts of a new initiative known as the Institute for Clinical & Economic Review (ICER), a new initiative of Harvard Medical School, that seeks to provide an impartial review of new or emerging healthcare technologies that involves ALL relevant stakeholders (including patients). We are currently evaluating permanent brachytherapy and proton beam therapy for prostate cancer, and would like to include patients who have undergone each of these treatments in our discussion.
Patient Advocacy
Who is your advocate?
Unfortunately, when you are feeling your worst is when you must be your most diligent. The battling cancer war includes a few small skirmishes along the way. No matter what your battle plan you should have help in the form of an advocate.
Here are just some of the reasons why.
1. Inputting information:You’ve just been diagnosed with cancer and you’re being overloaded with new terminology and massive amounts of information. Your advocate will be taking notes in the doctor’s office, at the clinic and anywhere you are introduced to new information. You can sit back and let your head spin.
2. Health care decisions: Post op, as you struggle with your nasogastric tube is not the time to wonder what your doctor said about treatment options, or where your notes are on side effects of that new pill you took or to hope you have the strength to surf the web for information. Your advocate can help you sift through information, do research and assist you in making the best decision possible for your care.
3. Your barrier: The health care advocate is the person who stands between you and the world. Your advocate is the person who gets up and approaches that intimidating clerk in the waiting room and reminds them you have been waiting an hour. They will also block the door to your room when you are napping and someone wants to scrub your floor. Enough said.
4. Mistakes happen: No one likes to discuss mistakes, especially not your caregivers. But as long as there are humans, there will be human error. Your advocate has your medical history and can double check every pill brought to you and every IV bag that is hung.
5.Dealing with red-tape: The maze of insurance and hospital bureaucratic regulations is overwhelming when you feel 100%. Let your advocate play phone tag and chase paperwork from simple pre-qualification details to following up insurance payments.
6. The squeaky wheel gets greased: Here’s a little secret from the nurse’s break room. The patient with the annoying friend who keeps pushing the call button for pain meds exactly when they are due, is likely to get the nurse’s attention first. I’m not saying this is fair but then again, the cancer patient already knows life is far from fair.
7. Hand holding: There is much to be said for the simple human touch. Consider how much time passes in the typical hospital day without human touch–real human touch, not clinical touch, as though you were inanimate. The simple squeeze of a hand communicates far more eloquently and contributes more to your recovery than words.
How to Find an Advocate:
Consider who you trust and who you would be willing to be an advocate for if roles were reversed. Sometimes several close friends are willing to share your advocacy.
Additionally there are professionals whose job is patient advocacy; these include private duty nurses. They’ll put your needs first because they are being paid to. Ask you hospital social worker or doctor if they can recommend someone.
Cancer Patients and Pharmaceutical Compliance
Recently, Dr. Jose DeJesus of Physician Entrepreneur reported that many patients are opting not to heed all of their doctor’s orders when it comes to prescription medications. Some of the reasons cited include the skyrocketing cost of prescriptions, the breakdown in communication between the doctor to patient and poor education from the pharmacist.
From Pharmacy Patient Satisfaction and What it Means to Physicians: More →
Clinical Trial Now Enrolling Newly Diagnosed Cancer Patients
Several sites are recruiting cancer patients for a study entitled, “Stress Management Therapy in Patients Receiving Chemotherapy for Cancer.”
Where Do We Stand in the War on Cancer? The Biggest Advances in 2007
During his 1970 inaugural address, American President Richard Nixon declared a War on Cancer. Promising to allocate at least $100 million in funding to investigate the causes for what was then the second-leading cause of death in the United States, Nixon followed through in 1971 by signing the National Cancer Act. Key objectives of this act included infusing basic sciences research funding, ramping up clinical trials and making the National Cancer Institute a free-standing body under the National Institutes of Health.
Nearly forty years later, physicians and scientists are making great strides in better understanding the etiology, management and treatment in all forms of cancer. Recently, the American Society for Clinical Oncology released a report entitled, Clinical Cancer Advances 2007: Major Research Advances in Cancer Treatment, Prevention, and Screening. This annual review, which is available as a .pdf, podcast, and slideshow at the People Living With Cancer website, includes the following highlights:
Primary Liver Cancer Patients Get the Option for Systemic Treatment: Until recently, surgical techniques were the first line of treatment in liver cancer patients because response to chemotherapy was so poor. In 2007, results of a large study showed that advanced liver cancer using sorafenib (Nevaxar), a targeted chemotherapeutic, lived 44 percent longer than patients who did not. More →
Good News for Head and Neck Cancer Patients
While head and neck cancer is neither as frequent nor as deadly as other cancers worldwide, it is of particular interest to research scientists because of its inherent invasive and metastatic characteristics.
While chemotherapy and radiation are becoming more commonplace, surgery still plays a major role in treatment of the oral cavity and surrounding areas. An otolarygology fellow that I worked with once in a head and neck cancer laboratory once described the most severe cases as a cat and mouse game where the surgeons “chased” the cancerous cells from one site to another.
Cancer Patients Pave the Way to New Cures
Anyone who’s ever gone through cancer treatment can tell you that it’s not easy going through The Big Three — surgery, radiation, and chemotherapy. Below, Battling Cancer discusses the story of two individuals whose own cancer diagnoses inspired them to seek better treatment plans for themselves and others:
Neil Ruzic
A scientific writer and inventor, Neil Ruzic dedicated his life to asking questions and improving the scientific research climate. When he was diagnosed with mantle-cell lymphoma in 1998, he shunned traditional approaches to curative care in search of more nontoxic approaches. For four years, he visited several comprehensive cancer centers, investigated new cures in research laboratories, and enrolled in clinical trials. He compiled his research in a book entitled, Racing to a Cure: A Cancer Victim Refuses Chemotherapy and Finds Tomorrow’s Cures in Today’s Scientific Laboratories. Before he passed away in 2004, he founded the Ruzic Research Foundation, a non-profit organization dedicated to funding experimental approaches to lymphoma treatment. More →
Tina Radcliffe spent ten years as a Oncology Certified R.N. working with in-patients on oncology and med-surg units. She also has a background in home health and geriatrics. Her other experiences include ... .. 
